MYMD PHARMACEUTICALS INC's ticker is and the CUSIP is 62856X102. A total of 48 filers reported holding MYMD PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 4.52 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $17,760 | -21.1% | 30,000 | +100.0% | 0.00% | 0.0% |
| Q2 2023 | $22,500 | -12.8% | 15,000 | 0.0% | 0.00% | -20.0% |
| Q1 2023 | $25,800 | +49.6% | 15,000 | 0.0% | 0.01% | +25.0% |
| Q4 2022 | $17,250 | -89.9% | 15,000 | -76.9% | 0.00% | -88.9% |
| Q3 2022 | $170,000 | – | 65,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M Holdings Securities, Inc. | 70,909 | $106 | 0.02% |
| Fidelis Capital Partners, LLC | 38,590 | $57,885 | 0.02% |
| Taylor & Morgan Wealth Management, LLC | 16,086 | $24,129 | 0.02% |
| Corundum Group, Inc. | 19,600 | $29,400 | 0.02% |
| Praetorian Wealth Management, Inc. | 25,000 | $37,500 | 0.01% |
| WALLED LAKE PLANNING & WEALTH MANAGEMENT, LLC | 14,000 | $21,000 | 0.01% |
| Cambria Investment Management, L.P. | 60,235 | $90,353 | 0.01% |
| Bridgecreek Investment Management, LLC | 15,000 | $22,500 | 0.00% |
| Mirae Asset Global Investments Co., Ltd. | 1,183,616 | $1,775,425 | 0.00% |
| NWAM LLC | 25,000 | $37,500 | 0.00% |